Managing Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations associated with Myeloid Malignancies; DNMT3A, TET2, JACK2-V617F

Angela Fleischman MD PhD UC Irvine discusses Disease Managing Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations associated with Myeloid Malignancies; DNMT3A, TET2, JACK2-V617F at MOASCs Spotlight On Hematology in Huntington Beach 2018.

 

 

 

 

clonal hematopoiesis, indeterminate potential (CHIP) mutations, myeloid malignancies, dnmt3a, tet2, jack2-v617f, moasc spotlight, hematology